SGC
AGN

South Georgia Capital’s Allergan plc AGN Stock Holding History

South Georgia Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$27K Buy
+100
New +$30.7K 0.07% 84

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

South Georgia Capital's AGN Position: Q3 2015 in Review

South Georgia Capital opened a new position in Allergan plc (AGN) in Q3 2015: 100 shares worth $27K. The stake represents 0.07% of the portfolio and ranks #84 among its holdings.

1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • South Georgia Capital held 100 shares of Allergan plc worth $27K as of Q3 2015.
  • Allergan plc was a new South Georgia Capital position in Q3 2015.
  • Allergan plc made up 0.07% of South Georgia Capital's portfolio in Q3 2015, its #84 holding.
  • 1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on South Georgia Capital's 13F filing for Q3 2015, filed 10 Nov 2015.